Carolyn Bertozzi

Nice piece by Dr. Li Peng, CSO of @Palleon_Pharma

Nice summary of ⁦@michal_stanczak⁩ and ⁦@LImmunotherapy⁩’s recent publication in ⁦@ScienceTM⁩ on Siglec/sialoglycan axis as target for cancer immune therapy, with the ⁦@Palleon_Pharma⁩ team and us as collaborators. #glycotime

Great issue, esp the article by @LImmunotherapy and @AlfredZippelius on immune therapies that target the TME in general and sialoglycan/Siglec axis in particular, some of the more promising candidates in the pipeline. #glycotime @Palleon_Pharma @InterVennBioSci

Great piece on @michal_stanczak, @LImmunotherapy and coworkers @Palleon_Pharma recent report on engineered sialidases for cancer immune therapy, delighted to contribute to this exciting #glycotime collaboration.

Exciting work from Noah Burns lab ⁦@StanfordUChem⁩ out in ⁦@J_A_C_S⁩ Aqueous Amine-Tolerant [2+2] Photocycloadditions of Unactivated Olefins | Journal of the American Chemical Society